Español
ABOUT US | CONTACT | VOLUNTEER
MISSION & MINISTRY
Find a Physician
Decrease (-) Restore Default Increase (+)

Intrauterine transfusion
Intrauterine transfusion


Antibodies
Antibodies


Definition:

Erythroblastosis fetalis is a potentially life-threatening blood disorder in a fetus or newborn infant. This article provides a general overview. For more detailed information see the specific disorder:



Alternative Names:

Hemolytic disease of the newborn



Causes, incidence, and risk factors:

Erythroblastosis fetalis develops in an unborn infant when the mom and the baby have different blood types. The mother produces substances called antibodies that attack the developing baby's red blood cells.

The most common form of erythroblastosis fetalis is ABO incompatibility , which can vary in its severity.

The less common form is called Rh incompatibility , which more often causes a very severe anemia in the baby.



Symptoms:

Symptoms in a newborn baby may include:



Signs and tests:

Specific tests depend on the type of erythroblastosis, but may include:

  • Complete blood count
  • Bilirubin level
  • Blood typing


Treatment:

After birth, depending on the severity, a transfusion usually needs to be performed.

For specific treatment information see:



Support Groups:



Expectations (prognosis):

The severity of this condition can vary widely. In some instances, the baby has no symptoms of the disease. In other cases, it can lead to death of the baby before or shortly after birth. It can be treated before birth by intrauterine transfusion.



Complications:

Complications depend on the specific type of erythroblastosis fetalis.



Calling your health care provider:



Prevention:

The most severe form of this disease, Rh incompatibility, can be prevented if the mother takes a medicine called RhoGAM at certain times during and after pregnancy. If you have had a baby with this disease, be sure to talk with your doctor if you plan on having another baby.




Review Date: 10/8/2007
Reviewed By: Deirdre O’Reilly, MD, MPH, Neonatologist, Division of Newborn Medicine, Children’s Hospital Boston and Instructor in Pediatrics, Harvard Medical School, Boston, Massachusetts. Review Provided by VeriMed Healthcare Network.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com


About Us



Emanuel Cancer Centers 2013 Annual Report
Joint Notice of Privacy Practices
Accreditation & Quality Measures
Board of Directors
CEO's Message
Community Crisis Information
Maps & Directions
Mission & Ministry
News & Publications
Volunteer

Care & Services



Emanuel Physician Finder

Employees & Physicians



Tenet Application Process
e-MC Physician Portal
Web Mail
Employment Services
Physician Verification
Living in Turlock
Contact Us

Emanuel Medical Center
825 Delbon Avenue
Turlock, CA 95382
(209) 667-4200
Contact Us
© 2014 Emanuel Medical Center, Inc. All rights reserved
Home   |   Site Map   |   Joint Notice of Privacy Practices